Melatonin combined with antineoplastic drugs or natural products for cancer treatment: An update.
1/5 보강
Drug combinations have shown promise in suppressing drug resistance, improving drug efficacy, and reducing side effects in anticancer therapy.
APA
Trejo-Solís C, Rojas-Tomé IS, et al. (2025). Melatonin combined with antineoplastic drugs or natural products for cancer treatment: An update.. Current research in pharmacology and drug discovery, 9, 100239. https://doi.org/10.1016/j.crphar.2025.100239
MLA
Trejo-Solís C, et al.. "Melatonin combined with antineoplastic drugs or natural products for cancer treatment: An update.." Current research in pharmacology and drug discovery, vol. 9, 2025, pp. 100239.
PMID
41341468 ↗
Abstract 한글 요약
Drug combinations have shown promise in suppressing drug resistance, improving drug efficacy, and reducing side effects in anticancer therapy. Considering that the anticancer activity of melatonin may be due to its antiproliferative, antioxidant, and immunomodulatory activities, the combined administration of this endogenous indoleamine with anticancer drugs has been extensively explored. This review provides an overview of the advances in the last five years in the anticancer activity of melatonin in combination with synthetic drugs and natural products. Papers on this topic were searched in PubMed, Google Scholar, Cochrane, and Scopus within the period 2018-2024. A total of 47 papers were retrieved showing a synergistic antitumor effect of melatonin combined with different drugs in the treatment of breast, colorectal, prostate, gastric, thyroid, and pancreatic cancer, as well as in head and neck squamous cell carcinoma, melanoma, and glioblastoma. The evidence gathered in this review will contribute to our knowledge of the use of melatonin. In addition, it may allow us to develop novel approaches to the treatment of cancer to be evaluated in preclinical and/or clinical trials.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- The role of disulfidptosis-driven tumor microenvironment remodeling in pancreatic cancer progression.
- A herbal formulation inhibits growth and survival of lung cancer cells through DNA damage and apoptosis - in vitro and in vivo studies.
- Mitocurcumin induces ROS-/JNK-mediated paraptosis to overcome chemoresistance in non-small cell lung cancer.
- Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia.
- RETREG1/FAM134B-mediated micro-ER-phagy in the retrovirus-SERINC5 arms race.
- Risks, Benefits, and Molecular Targets of Fenugreek Administration in the Treatment of Hepatocellular Carcinoma.